{"schema_version":"1","generated_at":"2026-11-19T11:14:47.599Z","data_as_of":null,"url":"https://www.findmykol.com/kol/shelly-lee","json_url":"https://www.findmykol.com/kol/shelly-lee/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"shelly-lee","name":"Shelly Lee","credential":"MD","specialty":"Ophthalmology","specialty_raw":"Ophthalmology","therapeutic_area":"Ophthalmology","therapeutic_areas":["Ophthalmology"],"institution":"Spokane Eye Clinic Ps","institution_url":"https://www.findmykol.com/institution/spokane-eye-clinic-ps","city":"Spokane","state":"WA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Shelly Lee is an Ophthalmology physician affiliated with Spokane Eye Clinic Ps. OpenAlex indexes 6 publications with 319 citations (h-index 4).","overview":null,"focus":{"indications":[],"research_topics":["Ophthalmology"]},"scholarship":{"works_count":6,"cited_by_count":319,"h_index":4,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":13,"program_years":{"first":2021,"last":null},"rows_total":24,"shown":3,"withheld":21,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":177.42,"payment_count":4},{"payer":"ANI Pharmaceuticals, Inc.","program_year":2025,"amount_usd":92.67,"payment_count":4},{"payer":"Astellas Pharma US Inc","program_year":2025,"amount_usd":92.19,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":87.9,"classes_total":1,"classes":[{"class":"Ester Local Anesthetic","setting":"administered","share_pct":87.9,"drugs":[{"name":"Chloroprocaine hcl ophthalmic","share_pct":100}],"max_beneficiaries":93}]},{"area":"Sensory organs","share_pct":10.5,"classes_total":8,"classes":[{"class":"Antineovascularisation agents","setting":"administered","share_pct":9.8,"drugs":[{"name":"Faricimab-svoa","share_pct":100}],"max_beneficiaries":44},{"class":"Vascular Endothelial Growth Factor Inhibitor","setting":"administered","share_pct":0.4,"drugs":[{"name":"Ranibizumab","share_pct":100}],"max_beneficiaries":25}]},{"area":"Cancer & immunology","share_pct":1.5,"classes_total":3,"classes":[{"class":"Vascular Endothelial Growth Factor Inhibitor","setting":"administered","share_pct":1,"drugs":[{"name":"Aflibercept","share_pct":100}],"max_beneficiaries":125},{"class":"Complement Inhibitor","setting":"administered","share_pct":0.5,"drugs":[{"name":"Pegcetacoplan","share_pct":100}],"max_beneficiaries":12}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":6,"shown":5,"withheld":1,"matched_by":"OpenAlex author record","recent":[{"title":"Rituximab Therapy for Refractory Scleritis","year":2014,"journal":"Ophthalmology","source_url":"https://doi.org/10.1016/j.ophtha.2014.04.044","status":"verified"},{"title":"Rituximab Therapy for Refractory Orbital Inflammation","year":2014,"journal":"JAMA Ophthalmology","source_url":"https://doi.org/10.1001/jamaophthalmol.2013.8179","status":"verified"},{"title":"Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial","year":2013,"journal":"British Journal of Ophthalmology","source_url":"https://doi.org/10.1136/bjophthalmol-2012-302292","status":"verified"},{"title":"THE USE OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR FOR CHOROIDAL NEOVASCULARIZATION COMPLICATING POSTERIOR UVEITIS IN EYES WITH FLUOCINOLONE ACETONIDE IMPLANTS","year":2012,"journal":"Retinal Cases & Brief Reports","source_url":"https://doi.org/10.1097/icb.0b013e31825d8152","status":"verified"},{"title":"The Treatment of Recurrent Central Serous Chorioretinopathy with Intravitreal Bevacizumab","year":2011,"journal":"Journal of Ocular Pharmacology and Therapeutics","source_url":"https://doi.org/10.1089/jop.2011.0045","status":"verified"}],"source":"works"},"contact":{"address_1":"427 S BERNARD ST","city":"Spokane","state":"WA","zip":"992042509","phone":"509-456-0107","source":"identity"},"similar":[{"name":"Robert Weinreb","slug":"robert-weinreb","institution":"University of California San Diego","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/robert-weinreb","json_url":"https://www.findmykol.com/kol/robert-weinreb/profile.json"},{"name":"Emily Chew","slug":"emily-chew","institution":"National Eye Institute","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/emily-chew","json_url":"https://www.findmykol.com/kol/emily-chew/profile.json"},{"name":"Carol Shields","slug":"carol-shields","institution":"Wills Eye Hospital","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/carol-shields","json_url":"https://www.findmykol.com/kol/carol-shields/profile.json"},{"name":"Harry Quigley","slug":"harry-quigley","institution":"Johns Hopkins University School of Medicine","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/harry-quigley","json_url":"https://www.findmykol.com/kol/harry-quigley/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":21,"publications":1}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-08-01","provider_certified":"2024-08-01","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}